Bejelentkezés Regisztrálj ingyen

AMAG Pharmaceuticals Jövedelem

Mi az AMAG Pharmaceuticals Jövedelem?

A Jövedelem az AMAG Pharmaceuticals, Inc. - -$227.96

Mi a Jövedelem meghatározása?

A közös részvényesek számára rendelkezésre álló nettó jövedelem egyenlő a nettó jövedelemmel mínusz a kifizetett előnyben részesített osztalékokkal.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Jövedelem a Health Care szektor a NASDAQ-on cégekben a AMAG Pharmaceuticals -hoz képest

Mit csinál AMAG Pharmaceuticals?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

jövedelem -hoz hasonló cégek AMAG Pharmaceuticals